ARCHIVES

In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored

This article is from The Cancer Letter archive.

Vol. 16 No. 41 | October 26, 1990

Download PDF Visit The Full Archive

Related Articles

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987

Nine Saturation Program Planning Contracts Approved

May 9, 1975

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

Arthur Upton New Name In Director Race; Califano Meets With Prospects

May 6, 1977

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

Centers Subcommittee Kills Guidelines Proposal, Suggest Formula Ceiling On Core Grants

January 6, 1978